State of Wisconsin Investment Board
CRVS icon

State of Wisconsin Investment Board’s Corvus Pharmaceuticals CRVS Stock Holding History

State of Wisconsin Investment Board’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,500
Closed -$74K – 1552
2019
Q1 		$74K Buy
18,500
+4,200
+29% +$17.7K ﹤0.01% 1518
2018
Q4 		$52K Buy
+14,300
New +$97.5K ﹤0.01% 1520

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State of Wisconsin Investment Board's CRVS Position: Q2 2019 in Review

State of Wisconsin Investment Board sold out of Corvus Pharmaceuticals (CRVS) in Q2 2019, closing a stake of 18,500 shares — an estimated $74K sold.

State of Wisconsin Investment Board first reported a position in CRVS in Q4 2018 and held it in 2 quarters. The position peaked at $74K in Q1 2019. 45 funds tracked by Wall St. Rank hold CRVS as of Q2 2019.

  • State of Wisconsin Investment Board reported no remaining Corvus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 18,500 Corvus Pharmaceuticals shares in Q2 2019, an estimated $74K.
  • State of Wisconsin Investment Board first reported a position in Corvus Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Corvus Pharmaceuticals position peaked at $74K in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2019, filed 14 Aug 2019.